ARS-Patent writes about new domestic regulations intended to fight evergreening of pharmaceutical patents May 14, 2019 Anna Pustogvar, patent expert at ARS-Patent, and Kirill Osipov, the Head of Legal Department of ARS-Patent, have been published in spring Newsletters of the AIPLA Chemical Practice Committee. They write about new domestic regulations intended to prevent evergreening of pharmaceutical patents. Read the publication here (the PDF version is provided by AIPLA Chemical Practice Committee) Make an enquiry
MEET WITH US Meet ARS-Patent at the AIPPI World Congress 20262026-08-26The AIPPI World Congress 2026 will be held in Hamburg, Germany, from 7 to 10 October 2026, bringing together thousands of intellectual property profes...Read moreARS-Patent will attend the APAA 2025 in Kuala Lumpur2025-10-03We are pleased to announce that ARS-Patent will be a part of the upcoming global IP event APAA 2025, which is the 21st General Assembly and 77th & 78t...Read moreSee all Events
Meet ARS-Patent at the AIPPI World Congress 20262026-08-26The AIPPI World Congress 2026 will be held in Hamburg, Germany, from 7 to 10 October 2026, bringing together thousands of intellectual property profes...Read more
ARS-Patent will attend the APAA 2025 in Kuala Lumpur2025-10-03We are pleased to announce that ARS-Patent will be a part of the upcoming global IP event APAA 2025, which is the 21st General Assembly and 77th & 78t...Read more
